article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4 As of October 2023, 62.93

article thumbnail

When Worlds Collide: The Theory of Real-World Evidence Meets Reality

The FDA Law Blog

Based on a review of premarket submissions made in 2012 through 2019, FDA identified 90 examples of 510(k)s, De Novos, HDEs, and PMAs approved/cleared which utilized RWE in support of regulatory decision-making. Every use of ESD is recorded, as is every behavior that falls within the intended use.

FDA 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hospital pharmacist-led re-evaluation of medication errors: a pilot study

Hospital Pharmacy Europe

Information on the medication errors, their narrative information and classifications were exported to Microsoft Excel for reclassification by two trained hospital pharmacists. If information such as the route of administration, the medical record system involved and the location of where the incident occurred (e.g.

article thumbnail

What conditions qualify for disability benefits?

The Checkup by Singlecare

Don’t avoid employment simply because you’re receiving SSI. musculoskeletal – adult , SSA Disability evaluation under Social Security 2.00 special senses and speech – adult , SSA Disability evaluation under Social Security 3.00 respiratory – adult , SSA Disability evaluation under Social Security 4.00

article thumbnail

FOSTAIR inhaler – TOP questions & ANSWERS

Druggist

In 2012 licensed was updated and since then Fostair can also be used as a reliever , taken accordingly to asthma symptoms. You may need to consent to allow access to your Summary Care Records (SCR). Accessing SCR would allow conformation between information provided during your order and NHS records.

article thumbnail

Adherence to NICE criteria for initiation and continuation of treatment with a biologic in atopic dermatitis

Hospital Pharmacy Europe

Dermatology correspondence (as part of the medical record) were examined as far back as 2012 if necessary for relevant information about patients’ treatment. Relevant data (patient demographics and treatment details) were imported into Excel by a member of the pharmacy team.

article thumbnail

Levonorgestrel Intrauterine Device for Emergency Contraception

Birth Control Pharmacist

Participants were instructed to follow-up one month after IUD insertion for a urine pregnancy test, but even if they did not follow-up, their medical records for the following six months were reviewed to verify if a pregnancy was ever detected. 2012; 27:1994-2000. Why the Levonorgestrel IUD? N Engl J Med. 2021; 384:335-44.